We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NXT:NASDAQNextpower Inc. Analysis

Data as of 2026-04-21 - not real-time

$110.46

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Nextpower Inc. is trading at $110.46, comfortably above its near‑term support of $103.73 and below the DCF‑derived fair value of $118.81, implying roughly a 13% upside. The stock sits in a bullish technical environment with the 20‑day SMA ($114.93) above the 50‑day SMA ($114.61) and both well above the 200‑day SMA ($90.35), while the MACD shows a bearish divergence but the RSI at 47 suggests room for upward movement. Fundamental metrics reinforce the case: revenue surged 34% YoY, operating margin sits at 19.4%, and ROE exceeds 33%, all while the company holds ample cash ($952M) against modest debt ($45M).
However, the sector carries elevated risk—beta of 1.82 and a 30‑day volatility of over 70% signal price swings, and the solar industry remains sensitive to policy shifts. The market’s “Extreme Greed” sentiment (fear‑greed index 86) may be inflating short‑term enthusiasm, yet the lack of dividend and a high price‑to‑book ratio (7.6×) warrant caution. Overall, the combination of strong growth fundamentals, undervalued pricing relative to DCF, and a bullish technical backdrop supports a cautious but positive outlook.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above immediate support and below resistance
  • Neutral RSI and bearish MACD histogram
  • Stable volume indicating adequate liquidity

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervaluation vs DCF fair value (+13% upside)
  • Strong revenue growth (34% YoY) and high operating margins
  • Bullish SMA alignment and overall bullish trend direction

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Secular tailwinds for solar tracker technology
  • Robust profitability metrics (ROE >30%, free cash flow positive)
  • High beta and volatility balanced by solid balance sheet and cash reserves

Key Metrics & Analysis

Financial Health

Revenue Growth33.90%
Profit Margin16.43%
P/E Ratio28.2
ROE33.17%
ROA13.61%
Debt/Equity2.08
P/B Ratio7.6
Op. Cash Flow$628.8M
Free Cash Flow$454.2M
Industry P/E36.9

Technical Analysis

TrendBullish
RSI47.6
Support$103.73
Resistance$131.72
MA 20$114.93
MA 50$114.61
MA 200$90.35
MACDBearish
VolumeStable
Fear & Greed Index86.07

Valuation

Fair Value$118.81
Target Price$125.19
Upside/Downside13.34%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta1.82
Volatility70.67%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.